12-16-2021, 11:44 PM
Pfizer Inc. agreed to buy Arena Pharmaceuticals Inc. in a deal valued at about $6.7 billion that brings potential therapies targeting immuno-inflammatory diseases.
The drug giant will pay $100 a share in an all-cash transaction for San Diego-based Arena and its assets in gastroenterology, dermatology and cardiology, according to a statement Monday. That’s about double Arena’s Friday closing price.
Wow, an unusual coincidence that the Pfizer Jab causes inflammatory heart problems and then buys a company that deals with inflammatory heart therapies for twice the stock price and pays over 7 billion in cash. Business is good, but can be better
The drug giant will pay $100 a share in an all-cash transaction for San Diego-based Arena and its assets in gastroenterology, dermatology and cardiology, according to a statement Monday. That’s about double Arena’s Friday closing price.
Wow, an unusual coincidence that the Pfizer Jab causes inflammatory heart problems and then buys a company that deals with inflammatory heart therapies for twice the stock price and pays over 7 billion in cash. Business is good, but can be better
“If you want to know who rules over you, just look for who you are not allowed to criticize.”
― Voltaire
― Voltaire